{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:39:16Z","timestamp":1761766756111,"version":"3.40.5"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"10","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Parasitology"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In areas endemic for <jats:italic>Leishmania infantum<\/jats:italic>, an asymptomatic infection may be an indicator of the extent of transmission. The main goal of this study was to evaluate the applicability of measuring circulating immunological biomarkers as an alternative strategy to characterize and monitor <jats:italic>L. infantum<\/jats:italic> asymptomatic infections in combination with serological methods. To this end, 179 children from a region endemic for visceral leishmaniasis (VL), aged 1\u201310 years old, selected from a cross-sectional study, were identified as asymptomatic (<jats:italic>n<\/jats:italic> = 81) or uninfected (<jats:italic>n<\/jats:italic> = 98) by qPCR and\/or serological tests (ELISA using <jats:italic>L. infantum<\/jats:italic> soluble antigen and rK39), and, together with serum samples of children diagnosed with VL (<jats:italic>n<\/jats:italic> = 43), were subjected to avidity tests and cytokine levels measurement. Avidity rates (AR) ranging from 41 to 70% were found in 29 children (66%) from the asymptomatic group. On the other hand, high AR (above 70%) were observed in 27 children (64%) from the VL group. Logistic Regression and Classification and Regression Tree (CART) analyses demonstrated that lower AR and IFN-<jats:italic>\u03b3<\/jats:italic> production associated with higher IL-17A levels were hallmarks in asymptomatic <jats:italic>L. infantum<\/jats:italic> infections. Therefore, this study proposes an association of immunological biomarkers that can be used as a complementary strategy for the characterization and monitoring of asymptomatic VL infections in children living in endemic areas.<\/jats:p>","DOI":"10.1017\/s0031182020000852","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T03:31:46Z","timestamp":1590636706000},"page":"1124-1132","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["Prospection of immunological biomarkers for characterization and monitoring of asymptomatic <i>Leishmania<\/i> (<i>Leishmania<\/i>) <i>infantum<\/i> infection"],"prefix":"10.1017","volume":"147","author":[{"given":"Gisele Mac\u00eado Rodrigues","family":"da Cunha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9390-7714","authenticated-orcid":false,"given":"Mari\u00e2ngela","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Ant\u00f4nio","family":"Pascoal-Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iara Caixeta Marques","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-8294","authenticated-orcid":false,"given":"Fernanda do Carmo","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"S0031182020000852_ref13","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86822005000200002"},{"key":"S0031182020000852_ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01208"},{"key":"S0031182020000852_ref4","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.67.344"},{"key":"S0031182020000852_ref20","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1983.32.943"},{"key":"S0031182020000852_ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2005.01686.x"},{"key":"S0031182020000852_ref36","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00367-13"},{"key":"S0031182020000852_ref9","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762012000600005"},{"key":"S0031182020000852_ref18","first-page":"58","article-title":"Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis","volume":"56","author":"Galv\u00e3o-Castro","year":"1984","journal-title":"Clinical Experimental Immunology"},{"key":"S0031182020000852_ref39","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.65.583"},{"key":"S0031182020000852_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2008.02.007"},{"key":"S0031182020000852_ref37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-6851(92)90208-2","article-title":"Sequence analysis of small subunit RNA genes and its use for detection and identification of Leishmania parasites","volume":"51","author":"Van Eys","year":"1992","journal-title":"Molecular and Biochemical Parasitology"},{"key":"S0031182020000852_ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141700"},{"key":"S0031182020000852_ref29","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"S0031182020000852_ref23","doi-asserted-by":"publisher","DOI":"10.1590\/S1413-86702009000100010"},{"key":"S0031182020000852_ref24","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86822006000500001"},{"key":"S0031182020000852_ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000536"},{"key":"S0031182020000852_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90340-1"},{"key":"S0031182020000852_ref17","first-page":"71","article-title":"Immune response to Toxoplasma gondi","volume":"40","author":"Filisetti","year":"2004","journal-title":"Annali dell'Istituto Superiore di Sanit\u00e0"},{"key":"S0031182020000852_ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001955"},{"key":"S0031182020000852_ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035671"},{"key":"S0031182020000852_ref3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.3.758"},{"key":"S0031182020000852_ref5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.2.775"},{"key":"S0031182020000852_ref6","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86822001000500007"},{"key":"S0031182020000852_ref8","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.334"},{"key":"S0031182020000852_ref10","doi-asserted-by":"publisher","DOI":"10.1179\/2047773213Y.0000000078"},{"key":"S0031182020000852_ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-018-3166-0"},{"key":"S0031182020000852_ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004375"},{"key":"S0031182020000852_ref16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.5.1124"},{"key":"S0031182020000852_ref22","doi-asserted-by":"publisher","DOI":"10.1086\/313697"},{"key":"S0031182020000852_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(95)01892-1"},{"key":"S0031182020000852_ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03171.x"},{"key":"S0031182020000852_ref35","first-page":"568","article-title":"Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen","volume":"9","author":"Singh","year":"2002","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"S0031182020000852_ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007493"},{"key":"S0031182020000852_ref31","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00149-06"},{"key":"S0031182020000852_ref32","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-0747"},{"key":"S0031182020000852_ref33","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala-azar caused by Leishmania donovani","volume":"119","author":"Romano","year":"2009","journal-title":"Journal of Clinical Investigation"},{"key":"S0031182020000852_ref34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000584"},{"volume-title":"Leishmaniasis Geneva: World Health Organization","year":"2019","key":"S0031182020000852_ref38"},{"key":"S0031182020000852_ref2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/154.6.1003"}],"container-title":["Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0031182020000852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T09:13:53Z","timestamp":1744794833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0031182020000852\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0031182020000852"],"URL":"https:\/\/doi.org\/10.1017\/s0031182020000852","relation":{},"ISSN":["0031-1820","1469-8161"],"issn-type":[{"type":"print","value":"0031-1820"},{"type":"electronic","value":"1469-8161"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2020. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}